INTEC PHARMA LTD. Net Change in Cash
INTEC PHARMA LTD. reported Net Change in Cash of $7.80 million for the 9-month period ending 2020-09-30, per its 10-Q filed 2020-11-05.
Discontinued › Cash Flow › Change in Cash
us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease · last filed 2020-11-05
- INTEC PHARMA LTD. cash and cash equivalents, period increase (decrease) for the quarter ending 2020-09-30 was $3.25M.
- INTEC PHARMA LTD. cash and cash equivalents, period increase (decrease) for the quarter ending 2020-06-30 was $2.82M.
- INTEC PHARMA LTD. cash and cash equivalents, period increase (decrease) for the quarter ending 2020-03-31 was $1.74M.
- INTEC PHARMA LTD. cash and cash equivalents, period increase (decrease) for the quarter ending 2019-09-30 was -$5.74M.
- INTEC PHARMA LTD. cash and cash equivalents, period increase (decrease) for fiscal 2018 was -$13.32M, a 136.16% decline from fiscal 2017.
- INTEC PHARMA LTD. cash and cash equivalents, period increase (decrease) for fiscal 2017 was $36.83M.
| Period end | Cash and Cash Equivalents, Period Increase (Decrease) 3 month | Cash and Cash Equivalents, Period Increase (Decrease) 6 month | Cash and Cash Equivalents, Period Increase (Decrease) 9 month | Cash and Cash Equivalents, Period Increase (Decrease) 12 month |
|---|---|---|---|---|
| 2020-09-30 | $3.25M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $6.07M derived: sum of 2 quarters · filed 2020-11-05 | $7.80M 10-Q · filed 2020-11-05 | |
| 2020-06-30 | $2.82M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-05 | $4.56M 10-Q · filed 2020-08-05 | ||
| 2020-03-31 | $1.74M 10-Q · filed 2020-05-11 | |||
| 2019-09-30 | -$5.74M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | -$16.47M derived: sum of 2 quarters · filed 2020-11-05 | -$24.21M 10-Q · filed 2020-11-05 | -$36.49M derived: sum of 4 quarters · filed 2020-11-05 |
| 2019-06-30 | -$10.73M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-05 | -$18.47M 10-Q · filed 2020-08-05 | -$30.75M derived: sum of 3 quarters · filed 2020-08-05 | -$42.65M derived: sum of 4 quarters · filed 2020-08-05 |
| 2019-03-31 | -$7.74M 10-Q · filed 2020-05-11 | -$20.02M derived: sum of 2 quarters · filed 2020-05-11 | -$31.93M derived: sum of 3 quarters · filed 2020-05-11 | -$8.83M derived: sum of 4 quarters · filed 2020-05-11 |
| 2018-12-31 | -$12.28M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-27 | -$24.18M derived: sum of 2 quarters · filed 2019-11-12 | -$1.09M derived: sum of 3 quarters · filed 2019-11-12 | -$13.32M 10-K · filed 2019-02-27 |
| 2018-09-30 | -$11.91M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | $11.19M derived: sum of 2 quarters · filed 2019-11-12 | -$1.04M 10-Q · filed 2019-11-12 | |
| 2018-06-30 | $23.10M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-09 | $10.87M 10-Q · filed 2019-08-09 | ||
| 2018-03-31 | -$12.23M 10-Q · filed 2019-05-07 | |||
| 2017-12-31 | $36.83M 10-K · filed 2019-02-27 |